49th Annual UCLA State-of-the-Art Urology Conference

This course explores the most challenging management problems facing the practicing urologist. Distinguished faculty present current information and techniques in urologic oncology (prostate, bladder, kidney), male and female voiding dysfunction, incontinence,  urinary tract infection, BPH surgical therapies, stone disease, penile implants, hypogonadism, prostate cancer focal and radiation therapy, perineal prostate biopsy, active surveillance, genetic testing, advanced prostate cancer therapy, non-muscle invasive bladder cancer, upper tract TCCA, renal and adrenal tumors, practice management, urethral stricture disease, and gender affirming care. The conference emphasizes interaction between participants and faculty and allows ample time for case presentations and group discussions, ensuring an outstanding educational experience for attendees.

In-person Registration Fee
$600.00 Physicians
$400.00 David Geffen School of Medicine at UCLA Faculty
$325.00 Non-Physician, Healthcare Professionals
$160.00 Residents (accompanied by a confirmatory letter of status from department chief or training director) 

Virtual Live Stream Option Registration Fee
$600.00 Physicians
$400.00 David Geffen School of Medicine at UCLA Faculty
$325.00 Non-Physician, Healthcare Professionals
$160.00 Residents (accompanied by a confirmatory letter of status from department chief or training director) 

Refunds
Cancellations must be received by February 1, 2024 by email to [email protected] and will be subject to a $75 processing fee. No refunds will be given after that date. If, for any reason, the course must be canceled, discontinued, or rescheduled, a full refund will be provided.

Course Recording
The course will not be recorded.

1. Tailor BPH surgical therapy
2. Perform penile implant surgery and manage complications
3. Manage hypogonadism with novel therapies
4. Utilize perineal biopsy in clinical practice
5. Manage prostate cancer recurrence after primary therapy
6. Perform continence sparing techniques during radical prostatectomy
7. Utilize focal therapy for prostate cancer
8. Manage advanced prostate cancer
9. Manage non-muscle invasive bladder cancer
10. Manage patients with upper tract urothelial cancer
11. Perform partial nephrectomy
12. Manage adrenal lesions
13. Manage the spectrum of kidney cancer including the small renal mass
14. Manage male and female voiding dysfunction including pelvic floor dysfunction
15. Manage post-prostatectomy incontinence
16. Utilize supplements for UTI prevention
17. Manage kidney stone disease and stones during pregnancy
18. Perform mini-percutaneous stone surgery
19. Understand important aspects of gender affirming care

The David Geffen School of Medicine at UCLA designates this live activity for a maximum of 22.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Society of Radiologic Technologists Credit
Approved by the ASRT for Category A continuing education credit.

UCLA Meyer and Renee Luskin Conference Center
425 Westwood Plaza
Los Angeles, CA 90095
855-522-8252
www.luskinconferencecenter.ucla.edu 

Accommodations
The Luskin Conference Center features 254 beautifully-appointed guest rooms, many with sweeping views of the stunning campus architecture and beautifully landscaped grounds. The gracious guest experience at the Luskin Conference Center is further enhanced by a full-service restaurant and lounge, on-site professional catering services, well-equipped fitness center, business center, and free Wi-Fi throughout the property.

UCLA has arranged a room block at the Luskin Conference Center for our guests. Room Rate ranges from $319 to $519 per night. Each individual guest must make their own reservations.

**GROUP RATE of $319.00 will apply to early arrivals and late departures (by 3 days) based upon availability. Guests will need to call in to the Reservations Department in order to secure this special rate on these dates.** Please note that room rates are subject to taxation which is currently 16%.

You may also call 855-LCC-UCLA (522-8252). All reservations must be guaranteed with a major credit card. Reservations must be made by January 30, 2024. The group code is LG2303UROA.

Once the room block is filled, room rates will be subject to availability. 

Directions and Parking
From the 405 freeway, exit Wilshire Blvd., East toward Westwood. Turn left on Westwood Blvd., travel past Charles E. Young Dr. South and turn left on Structure 8 driveway. Drive up the ramp to the rooftop level to park. Pay stations are located up on the roof top. All day self-parking is $15. There is a convenient walkway/bridge connecting Parking Structure 8 (on level 3) to the Luskin Conference Center Property. The Luskin Conference Center is located at Westwood Plaza and Strathmore Place.

Overnight self parking is available at The Luskin Conference Center at $32 per night. There is also self-parking available at Parking Structure 8 at $26 per night.

All parking rates are subject to change. For additional information, please visit: https://luskinconferencecenter.ucla.edu/about/campus-map-parking/. 

Mitigation of Relevant Financial Relationships

The Accreditation Council for Continuing Medical Education (ACCME), Standards for Integrity and Independence mandates that the accreditation manages all identified relevant financial relationship(s) before the program and adequately discloses relationships to learners. The David Geffen School of Medicine at UCLA adheres to the ACCME Standards for Integrity and Independence in accredited continuing education.

The individuals below have been identified as having a position to influence the content of this educational activity. As such, they have disclosed the absence or presence of a relevant financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All of the relevant financial relationships for these individuals have been mitigated.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Ashley Leung
UCLA

Activity Coordinator

Nothing to disclose

Ericka Cunningham, MBA
UCLA David Geffen School of Medicine

CCPD Staff

Nothing to disclose

Charles Flippen II, MD, FAAN, FANA
David Geffen School of Medicine at UCLA

CCPD Staff

Nothing to disclose

Yunmi Kim
David Geffen School of Medicine at UCLA

CCPD Staff

Nothing to disclose

Marsha Vacirca, MA
UCLA

CCPD Staff

Nothing to disclose

Kimberly Valencia, CHCP
UCLA David Geffen School of Medicine

CCPD Staff

Nothing to disclose

William Aronson, MD
Department of Urology, UCLA

Course Director, Faculty

Consulting Fee-Pfizer (Any division)|Consulting Fee-Bayer (Any division)|Consulting Fee-Janssen (Any division)|Consulting Fee-AstraZeneca (Any division)

A. Lenore Ackerman, MD
Department of Urology, UCLA

Faculty

Advisor-AbbVie (Any division)|Grant or research support-MicrogenDx|Advisor-Watershed|Grant or research support-Medtronic (Any division) (Relationship has ended)

Zachery C Baxter, MD
Department of Urology, UCLA

Faculty

Nothing to disclose

Peter Black, MD, FACS, FRCSC
Khosrowshahi Family Chair Professor, Department of Urologic Sciences
Canada

Faculty

Advisor-see list in email

Wayne Brisbane, MD
Department of Urology, UCLA

Faculty

Consulting Fee-EDAP-TMS

Rafael Carrion, MD
Chariman at Department of Urology, University of South Florida

Faculty

Consulting Fee-Coloplast|Consulting Fee-Boston Scientific Boston Scientific|Consulting Fee-Endo Pharmaceuticals, Inc.

Albert J Chang, MD
University of California, Los Angeles

Faculty

Consulting Fee-Boston Scientific Boston Scientific|Consulting Fee-Palette Life Sciences (Relationship has ended)|Consulting Fee-GammaTile|Speakers Bureau-Myovant (Relationship has ended)

Thomas Chi, MD, MBA
Kutzmann Endowed Professor and Associate Chair for Clinical Affairs University of California San Francisco UCSF

Faculty

Nothing to disclose

Arnold Chin, MD
Department of Urology, UCLA

Faculty

Nothing to disclose

Nicholas Donin, MD
Department of Urology, UCLA

Faculty

Nothing to disclose

Alexandra Drakaki, MD, PhD
Associate Professor of Medicine and Urology Division of Hematology/Oncology

Faculty

Nothing to disclose

Matthew Dunn, MD
Department of Urology, UCLA

Faculty

Advisor-Boston Scientific Boston Scientific (Relationship has ended)|Grant or research support-Boston Scientific Boston Scientific|Consulting Fee-Karl Storz Endoscopy (Relationship has ended)

Sriram Eleswarapu, MD
Department of Urology, UCLA

Faculty

Nothing to disclose

Adam Kibel, MD, Chair, Department of Urology
DiNovi Family Distinguished Chair in Urology, Harvard Medical School

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Janssen Oncology|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Roche (Any division)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Pfizer (Any division)|Advisor-Bristol-Myers Squibb Company|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Cellvax|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Candell (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Profound

Ja-Hong Kim, MD
DGSOM

Faculty

Nothing to disclose

Mark S Litwin, MD
Professor and Chair Department of Urology, Professor of Health Policy and Management, David Geffen School of Medicine at UCLA

Faculty

Nothing to disclose

Leonard Marks, MD
Department of Urology, UCLA

Faculty

Ownership-Avenda Health

Kevin T McVary, MD, FACS
Director of the Center for Male Health, Professor of Urology Department of Urology, Stritch School of Medicine, Loyola University Medical Center

Faculty

Consulting Fee-Boston Scientific Corporation|Grant or research support-ProDeon|Advisor-ProDeon|Consulting Fee-Urotronic|Ownership-Uronext|Ownership-Rivermark|Advisor-Zenflow|Advisor-Francis Medical|Grant or research support-NIDDK|Honoraria-UpToDate

Jesse Mills, MD, Health Science Clinical Professor
Department of Urology, UCLA

Faculty

Grant or research support-Endo Pharmaceuticals, Inc.|Grant or research support-Boston Scientific Boston Scientific

Gladys Y Ng, MD
Department of Urology, UCLA

Faculty

Nothing to disclose

Nicholas G Nichols, MD, PhD
Department of Radiation Oncology, David Geffen School of Medicine at UCLA

Faculty

Consulting Fee-PrimeFour (Relationship has ended)|Grant or research support-Lantheus|Grant or research support-Janssen (Any division)

Victor Nitti, MD
Department of Urology, UCLA

Faculty

Grant or research support-AbbVie (Any division)|Paid consultant-Medtronic (Any division)

Mark Painter, BA, MBS, CPMA
PRS Managed Services

Faculty

Consulting Fee-Medtronic (Any division)|Consulting Fee-Boston Scientific Corporation|Consulting Fee-StreamDX|Consulting Fee-Emmanoflo|Consulting Fee-Photocure Inc./Karl Storz|Consulting Fee-Sonablate Corporation (Relationship has ended)|Consulting Fee-SRS Medical, Inc.|Consulting Fee-iUflow|Consulting Fee-Promaxo, Inc. (Relationship has ended)|Consulting Fee-Urogen

Parth M Patel, MD
Department of Urology, UCLA

Faculty

Paid consultant-Prodeon Medical|Paid consultant-ReSurge Therapeutics

Jacob Rajfer, MD
Department of Urology, UCLA

Faculty

Ownership-KLRM, LLC

Steven S Raman, MD
David Geffen School of Medicine at UCLA

Faculty

Nothing to disclose

Matthew B Rettig, MD
David Geffen School of Medicine at UCLA

Faculty

Consulting Fee-Johnson & Johnson|Consulting Fee-Bayer (Any division)|Consulting Fee (Relationship has ended)|Consulting Fee-Myovant Sciences|Speakers Bureau-Bayer (Any division)|Speakers Bureau-Johnson & Johnson|Grant or research support-Merck (Any division) Merck (Any division)|Grant or research support-Lantheus|Grant or research support|Grant or research support-Pfizer (Any division)|Grant or research support-Novartis Corporation Pharmaceuticals|Grant or research support-Amgen, Inc.

Kymora B Scotland, MD
UCLA

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Advanced MedTech|Consulting Fee-Karl Storz Endoscopy|Consulting Fee-Ambu, Inc.

Joseph D Shirk, MD
Department of Urology, UCLA

Faculty

Consulting Fee-Ceevra, Inc|Consulting Fee-Procept BioRobotics

Brian Shuch, MD
Department of Urology, UCLA

Faculty

Adam E Singer, MD
University of California, Los Angeles

Faculty

Consulting Fee-AVEO Oncology|Consulting Fee-Adaptyx Biosciences

Lynn Stothers, MD
UCLA Departments of Urology and Gynecology

Faculty

Nothing to disclose

Sandip P Vasavada, MD
Urology Director, Center for Female Urology and Reconstructive Pelvic Surgery, Cleveland Clinic, Glickman Urological Institute

Faculty

Advisor-Medtronic (Any division)

Karim Chamie, MD
Department of Urology, UCLA

Faculty, Other Planning Committee Member

Consulting Fee-Urogen

craig W canfield, M.D.
Urology Associates of the Central Coast

Other Planning Committee Member

Nothing to disclose

We regret to inform you that this course has reached full capacity. However, if you would like to secure a place on the waiting list, kindly reach out to us via email at [email protected].

Exhibiting at this event operates on a first-come, first-serve basis.
To exhibit, please follow the steps below:

1. Complete the provided form by downloading and electronically signing Letter Of Agreement.

• Urology Exhibitor LOA 24.pdf

2. Submit to the email address mentioned below.

3.Use the "Exhibit At This Event" button to process your payment.